FRANKLIN LAKES, N.J., March 15, 2016 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading medical technology company, announced today that BD MedMined® Surveillance Advisor has been named a 2015/2016 Category Leader for Infection Control and Monitoring in the 2015/2016 Best in KLAS: Software and Service report, based on customer feedback.
This award marks the sixth year that MedMined Surveillance Advisor has finished first in the Infection Control and Monitoring category by KLAS, a company that independently monitors health care information technology performance through the active participation of thousands of users of the products and services. The award was presented February 29 at the Healthcare Information and Management Systems Society (HIMSS) Annual Conference and Exhibition in Las Vegas.
"We are honored that hospitals and infection prevention professionals have once again ranked MedMined Surveillance Advisor as the best technology for Infection Control and Monitoring," said Bert Williams, vice president and general manager of MedMined Services for BD. "The MedMined approach streamlines infection monitoring, optimizes clinical staff workflow and fosters an integrated antimicrobial stewardship program for infection preventionists, pharmacists and physicians."
MedMined Surveillance Advisor provides automated infection surveillance and data mining proven to help hospitals identify and reduce health care associated infections (HAIs) and antimicrobial resistance. With its patented algorithm supporting the early detection of patterns of emerging pathogens, the infection prevention team is empowered to efficiently focus resources on developing trends in HAIs and multiple-drug resistant organisms. The combined surveillance package of alerts, reports, training and consulting services allows for more time to be spent on clinical intervention and patient care.
More information about MedMined Surveillance Advisor can be found at http://www.carefusion.com/our-products/browse-brands/medmined.
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, optimize respiratory care and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has more than 45,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health. For more information on BD, please visit www.bd.com.
KLAS is a research and insights firm on a global mission to improve healthcare delivery by amplifying the provider's voice. Working with thousands of healthcare professionals and clinicians, KLAS gathers data and insights on software, services and medical equipment to deliver timely reports, trends and statistical overviews. The research directly represents the provider voice and acts as a catalyst for improving vendor performance. Follow KLAS on Twitter at www.twitter.com/KLASresearch.
BD Public Relations
Monique N. Dolecki
BD Investor Relations
SOURCE BD (Becton, Dickinson and Company)